Key Findings: The author focuses on the interactions of Δ9-THC, CBD, and Δ9-THCV and endocannabinoid receptors CB1 and CB2. The author also describes the Ki of CBG and Δ8-THC.
Type of Study: Meta-analysis
Study Result: Inconclusive
Research Location(s): United Kingdom
Year of Pub: 2008
Cannabinoids Studied: Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Tetrahydrocannabivarin (THCV), Delta-8-THC
Phytocannabinoid Source: Not Applicable
Receptors Studied: CB1, CB2
Citation: Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008; 153:199-215. doi: 10.1038/sj.bjp.0707442
Authors: Pertwee RG